About Daiichi Sankyo:
Daiichi Sankyo, Inc. (DSI), headquartered in Parsippany, NJ, is the U.S. subsidiary of Daiichi Sankyo Co., Ltd., a global pharmaceutical company. DSI was formed in 2006 from the integration of two leading pharmaceutical companies, Sankyo Pharma, Inc. and Daiichi Pharmaceutical Corporation.
Its team of nearly 3,000 U.S. employees is dedicated to the creation and supply of innovative pharmaceutical products to address the diversified, unmet medical needs of patients. DSI concentrates in the therapy areas of hypertension, thrombosis, dyslipidemia, diabetes and acute coronary syndrome. Clinical development and regulatory activities are headquartered at Daiichi Sankyo Pharma Development in Edison, NJ.
For a list of all of our openings please visit our website at their website.